We could not find any results for:
Make sure your spelling is correct or try broadening your search.
GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbo... GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection. Show more
Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 PR Newswire WALTHAM, Mass., Nov. 12, 2024 Company to highlight lead program CR-001, a tetravalent VEGF1 x PD-1...
GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that data from multiple clinical trials studying uproleselan in patients with acute myeloid leukemia (AML) have been accepted for presentation...
A Maryland-based biotech company is already dominating Tuesday’s session prior to the opening bell after it was announced that the company will be merging with Crescent To read the full...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.009 | 3.86266094421 | 0.233 | 0.2485 | 0.1912 | 732884 | 0.22076631 | CS |
4 | -0.061 | -20.1320132013 | 0.303 | 0.3662 | 0.1912 | 776438 | 0.27790469 | CS |
12 | 0.073 | 43.1952662722 | 0.169 | 0.63 | 0.1406 | 20903537 | 0.47658525 | CS |
26 | -0.018 | -6.92307692308 | 0.26 | 0.63 | 0.1406 | 11610111 | 0.44712058 | CS |
52 | -2.318 | -90.546875 | 2.56 | 3.5299 | 0.1406 | 6447484 | 0.49555613 | CS |
156 | -1.348 | -84.7798742138 | 1.59 | 4.16 | 0.1406 | 2396322 | 0.64552874 | CS |
260 | -5.278 | -95.615942029 | 5.52 | 6.09 | 0.1406 | 1666466 | 0.98537515 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions